Recombinant Escherichia coli O17:K52:H18 Ribosome-recycling factor (frr)

What is the biological function of ribosome-recycling factor in Escherichia coli?

Ribosome-recycling factor (RRF), the product of the frr gene in Escherichia coli, plays an essential role in protein biosynthesis by dissociating ribosomes from mRNA after termination of translation. Unlike release factors that are termination-codon specific and release peptide chains from peptidyl tRNA, RRF functions specifically to recycle the components of the translation machinery. It works cooperatively with GTP and elongation factor G (EF-G) to dissociate the post-termination complex into its individual components: tRNA, ribosomes, and mRNA. This recycling process is critical for making these components available for subsequent rounds of protein synthesis .

The frr gene is essential for bacterial growth, as demonstrated through experimental studies where E. coli strains with frame-shifted frr in the chromosome and wild-type frr on a temperature-sensitive plasmid showed temperature-sensitive growth patterns. When the plasmid-encoded wild-type frr was inactivated at non-permissive temperatures, bacterial growth ceased, confirming the indispensable nature of this factor for cellular viability .

How do regulatory requirements differ when working with Recombinant E. coli O17:K52:H18 strains in research settings?

Research involving Escherichia coli O17:K52:H18 strains requires careful consideration of regulatory guidelines. According to NIH Guidelines, the regulatory requirements depend primarily on whether the strain is derived from K-12 or not:

• If the E. coli O17:K52:H18 strain is not derived from K-12 (like BL21 or Rosetta strains), it requires Institutional Biosafety Committee (IBC) review under NIH Guidelines section III-E .

• If it is derived from K-12, most research is exempt from IBC review under NIH Guidelines section III-F-8 and Appendix C-II, with certain exceptions .

Exceptions requiring IBC review even for K-12-derived strains include:

• Experiments involving culture volumes exceeding 10 liters

• Cloning genes from pathogens

• Cloning genes involved in toxin synthesis

For reference, the following table outlines the regulatory classification of various E. coli strains:

Researchers must determine the specific strain lineage of their E. coli O17:K52:H18 and consult with their institutional biosafety office to ensure compliance with all applicable regulations .

What expression systems are most efficient for producing Recombinant E. coli O17:K52:H18 Ribosome-recycling factor?

When expressing Recombinant E. coli O17:K52:H18 Ribosome-recycling factor, the choice of expression system significantly impacts yield and protein quality. Recent research indicates that optimizing the N-terminal sequences of recombinant proteins can increase production yield in E. coli up to 30-fold .

For ribosome-recycling factor expression, two primary vector systems have demonstrated efficacy:

For optimal expression of frr, directed evolution-based methodologies have proven effective. This approach involves:

• Creating DNA libraries with randomly modified N-terminal sequences

• Fusing these with the frr gene and a GFP reporter

• Using fluorescence-activated cell sorting (FACS) to identify high-expression variants

• Selecting and validating the highest-performing constructs

It's important to note that optimization is highly construct-specific; sequences that enhance expression of one protein may not work for others. Each protein requires its own optimization process, which can be time-consuming but yields significant benefits for proteins with naturally low expression levels .

How can directed evolution approaches be applied to optimize expression of E. coli O17:K52:H18 Ribosome-recycling factor?

Implementing directed evolution for optimizing Ribosome-recycling factor expression requires a systematic approach focused on N-terminal sequence modifications. This methodology leverages high-throughput screening to identify variants with enhanced expression profiles:

• Library Construction: Generate a diversified DNA library encoding various N-terminal sequences for the frr gene. This typically involves designing degenerate primers to create random variations in the first 5-15 codons following the start codon .

• Reporter System Development: Create a fusion construct where the frr gene is followed by a GFP reporter. The cycle 3 GFP variant is particularly effective as it exhibits increased fluorescence compared to wild-type GFP, proper maturation at 37°C, and reduced aggregation tendency .

• Library Transformation: Transform the library into an appropriate E. coli expression strain. For strong expression, BL21-Gold (DE3) can be used with T7 promoter systems, while other strains like TOP10 or XL-1 might be preferable for T5 promoter systems .

• Expression and FACS Sorting:

  • Induce protein expression (typical conditions: 18°C overnight for initial screening)

  • Perform FACS analysis to identify highly fluorescent cells

  • Set gating parameters based on positive (vector with GFP only) and negative (vector without GFP) controls

  • Sort cells exhibiting the highest fluorescence signals, indicating enhanced frr-GFP expression

• Validation and Scale-up:

  • Sequence selected clones to identify beneficial N-terminal modifications

  • Verify improved expression through small-scale protein production

  • Assess soluble vs. insoluble protein fraction ratios

  • Scale up production using optimized constructs

This approach has demonstrated up to 30-fold increases in soluble protein yield for various recombinant proteins. While the exact optimization is construct-specific, the methodology provides a powerful tool for enhancing expression of challenging proteins like Ribosome-recycling factor .

What are the critical factors affecting solubility of Recombinant E. coli O17:K52:H18 Ribosome-recycling factor during expression?

The solubility of Recombinant E. coli O17:K52:H18 Ribosome-recycling factor is influenced by multiple factors that can be strategically manipulated to enhance the proportion of correctly folded, functional protein:

For Ribosome-recycling factor specifically, employing a combination of these approaches—particularly N-terminal optimization through directed evolution—has proven most effective in maximizing the yield of soluble, functional protein .

How does the function of Ribosome-recycling factor differ between various E. coli strains, including O17:K52:H18?

While the core function of Ribosome-recycling factor (RRF) is conserved across E. coli strains, subtle structural and functional differences exist that may impact experimental outcomes and therapeutic applications:

For experimental applications, these differences have important implications:

• When using Recombinant E. coli O17:K52:H18 RRF for structural studies, researchers should recognize that findings may not be universally applicable to all E. coli strains

• For functional assays, controls should include RRF variants from multiple reference strains to account for strain-specific effects

• When RRF is targeted in antibacterial studies, strain variation should be considered in efficacy assessments

The essentiality of frr for bacterial growth has been definitively established through experimental validation. E. coli strain MC1061-2, which carried frame-shifted frr in the chromosome and wild-type frr on a temperature-sensitive plasmid, exhibited temperature-sensitive growth. At non-permissive temperatures (where the plasmid-encoded wild-type frr was inactivated), growth ceased entirely, demonstrating that functional RRF is indispensable for bacterial viability .

What purification strategies are most effective for isolating Recombinant E. coli O17:K52:H18 Ribosome-recycling factor?

Purifying Recombinant E. coli O17:K52:H18 Ribosome-recycling factor (RRF) to high homogeneity while maintaining its structural integrity and functional activity requires a strategic multi-step approach:

• Initial Clarification:

  • Harvest cells following optimized expression conditions (typically 3-4 hours post-induction at 30-37°C or overnight at 16-18°C)

  • Resuspend in buffer containing 50 mM Tris-HCl (pH 7.5), 100 mM NaCl, 1 mM EDTA, and protease inhibitors

  • Lyse cells via sonication or high-pressure homogenization

  • Centrifuge at 20,000 × g for 30 minutes to separate soluble fraction

• Affinity Chromatography Options:

  Tag System	First Purification Step	Elution Conditions	Advantages	Limitations
  His₆-tag	Ni-NTA or IMAC	250-300 mM imidazole	High affinity, simple protocol	Some background contaminants
  GST fusion	Glutathione Sepharose	10-15 mM reduced glutathione	Enhanced solubility, higher purity	Large tag may affect function
  MBP fusion	Amylose resin	10 mM maltose	Excellent solubility enhancement	Large tag requires removal

• Tag Removal and Secondary Purification:

  • For cleavable tags, incubate with appropriate protease (TEV, PreScission, or SUMO protease)

  • Remove cleaved tag and protease through reverse affinity chromatography

  • Perform size exclusion chromatography using Superdex 75 or similar matrix in buffer containing 20 mM HEPES (pH 7.5), 150 mM KCl, 5% glycerol

• Quality Assessment:

  • Verify purity via SDS-PAGE (>95% homogeneity)

  • Confirm identity through Western blotting and/or mass spectrometry

  • Assess structural integrity through circular dichroism spectroscopy

  • Validate functional activity through ribosome-binding and dissociation assays

For RRF specifically, researchers have found that incorporating a step-wise salt gradient during ion exchange chromatography (using Q-Sepharose or similar) efficiently separates RRF from contaminating nucleic acids that may co-purify due to RRF's natural affinity for RNA .

Optimized purification protocols typically yield 5-15 mg of highly pure RRF per liter of culture when using engineered N-terminal sequences identified through directed evolution approaches .

How can researchers effectively analyze structure-function relationships in Recombinant E. coli O17:K52:H18 Ribosome-recycling factor?

Analyzing structure-function relationships in Recombinant E. coli O17:K52:H18 Ribosome-recycling factor requires an integrated approach combining structural biology, biochemical assays, and computational analyses:

• Structural Characterization Methodologies:

  • X-ray Crystallography: Provides atomic-level resolution of RRF structure, requiring purification to >95% homogeneity and screening of crystallization conditions

  • Cryo-electron Microscopy: Particularly valuable for visualizing RRF in complex with ribosomal components

  • NMR Spectroscopy: Offers insights into dynamic aspects of RRF function, especially conformational changes during interaction with elongation factor G (EF-G)

  • Small-angle X-ray Scattering (SAXS): Provides structural information in solution, complementing crystallographic data

• Functional Assays to Correlate with Structural Data:

  • Ribosome Binding Assays: Quantifies the affinity of RRF variants for post-termination ribosomal complexes

  • Ribosome Recycling Assays: Measures the efficiency of ribosome dissociation in the presence of RRF, EF-G, and GTP

  • Translation Termination Assays: Evaluates the impact of RRF variants on protein synthesis termination efficiency

• Site-Directed Mutagenesis Strategy:
  Target specific structural elements for mutation based on:

  • Conserved residues across bacterial species

  • Amino acids at interaction interfaces with ribosomal components

  • Regions identified in crystallographic studies as undergoing conformational changes

• Computational Approaches:

  • Molecular Dynamics Simulations: Model conformational changes in RRF during ribosome interaction

  • Sequence-Structure-Function Correlation: Compare RRF sequences across bacterial species to identify functionally critical regions

  • Protein-Protein Docking: Predict interaction modes between RRF and ribosomal components or EF-G

When implementing this integrated approach, researchers should systematically catalog mutations using the following format:

This systematic approach allows researchers to map functional importance onto the structural framework of RRF, identifying critical regions for potential therapeutic targeting or protein engineering applications .

What are the methodological differences in studying Ribosome-recycling factor across various E. coli strains compared to O17:K52:H18?

When studying Ribosome-recycling factor across different E. coli strains compared to the O17:K52:H18 strain, researchers must employ specialized methodological approaches to account for strain-specific variations:

• Expression System Selection:

  • For K-12 derived strains: Standard laboratory expression systems are typically sufficient and exempt from additional regulatory requirements in most research contexts

  • For non-K-12 strains including O17:K52:H18: Expression may require specialized vectors optimized for the particular strain background, and research is subject to additional regulatory oversight

• Strain-Specific Optimizations:

  Strain Type	Growth Conditions	Expression Induction	Regulatory Considerations
  K-12 derived (e.g., DH5α, BL21)	Standard LB media, 37°C	IPTG 0.5-1.0 mM	Generally exempt from IBC review
  O17:K52:H18	May require strain-specific media supplements	Lower IPTG (0.1-0.5 mM) often optimal	Requires IBC review under NIH Guidelines III-E
  Pathogenic strains	BSL-2 conditions required	Tightly controlled expression systems	Requires IBC review under NIH Guidelines III-D

• Functional Analysis Considerations:

  • Interchangeability Testing: When studying functional conservation, researchers should create chimeric constructs where the frr gene from one strain replaces that of another to assess functional complementation

  • Growth Rate Analysis: Compare growth curves of strains expressing native versus heterologous RRF to quantify functional differences

  • Ribosome Binding Specificity: Purified ribosomes from different strains may exhibit varying affinities for RRF variants, requiring strain-specific binding assays

• Safety and Containment Protocols:

  • Research with non-K-12 E. coli strains requires following specific biosafety guidelines

  • Experiments with O17:K52:H18 may require dedicated equipment to prevent cross-contamination

  • Documentation and approval processes differ based on strain risk classification

A critical methodological consideration when working with O17:K52:H18 is that optimization approaches shown to enhance expression in one strain background may not transfer directly to other strains. For example, N-terminal sequence optimizations identified through directed evolution in a K-12 derived strain may require re-optimization when transferred to the O17:K52:H18 background due to differences in translational machinery and cellular environment .

How can Recombinant E. coli O17:K52:H18 Ribosome-recycling factor be utilized in antibiotic development research?

Recombinant E. coli O17:K52:H18 Ribosome-recycling factor (RRF) presents a promising target for antibiotic development due to its essential role in bacterial protein synthesis and absence in eukaryotic cells. Research applications in this area include:

• Target-Based Drug Screening:

  • Purified recombinant RRF can be employed in high-throughput screening assays to identify molecules that inhibit its function

  • The essential nature of RRF makes it an ideal antibiotic target, as demonstrated by experiments showing that loss of frr function leads to bacterial growth cessation

  • Screening approaches typically involve:

    • Fluorescence-based assays measuring RRF-ribosome binding

    • Functional assays monitoring ribosome recycling activity in the presence of candidate inhibitors

    • Thermal shift assays to identify compounds that alter RRF stability

• Structure-Based Drug Design:

  • Crystal structures of RRF can guide rational design of inhibitors targeting specific functional domains

  • Molecular docking studies can predict binding modes and inform medicinal chemistry optimization

  • Fragment-based approaches can identify chemical scaffolds with potential for development into full inhibitors

• Resistance Mechanism Studies:

  • Generating and characterizing RRF mutations that confer resistance to inhibitors provides valuable information about:

    • The inhibitor's binding site and mechanism of action

    • Potential clinical resistance pathways

    • Structural constraints on the evolution of resistance

• Combination Therapy Research:

  • RRF inhibitors can be studied in combination with existing antibiotics to identify synergistic effects

  • Since RRF functions in the final stage of protein synthesis, combining RRF inhibitors with other translation inhibitors may enhance efficacy and reduce resistance development

Research has demonstrated that the essentiality of frr makes it particularly valuable for antibiotic development. Unlike some bacterial targets that become dispensable under certain conditions, the absolute requirement for RRF function in bacterial growth ensures that resistance through target modification is constrained by functional requirements .

When developing assays for RRF inhibitor screening, researchers should incorporate controls that distinguish between compounds specifically inhibiting RRF function and those generally interfering with ribosomal activity, ensuring target specificity in identified candidates.

What are the current challenges in structural studies of Recombinant E. coli O17:K52:H18 Ribosome-recycling factor?

Structural studies of Recombinant E. coli O17:K52:H18 Ribosome-recycling factor face several technical challenges that researchers must address through specialized methodological approaches:

• Protein Expression and Purification Obstacles:

  • Yield Limitations: Native expression levels of RRF are often insufficient for structural studies requiring milligram quantities of protein

  • Conformational Heterogeneity: RRF's dynamic nature during its functional cycle can result in multiple conformational states in solution

  • Solution: Implementing directed evolution approaches to optimize N-terminal sequences can dramatically improve expression yield and solubility, with reports of up to 30-fold increases for challenging proteins

• Crystallization Challenges:

  • Dynamic Regions: Flexible regions in RRF can impede crystal formation

  • Surface Properties: The natural RNA-binding properties of RRF can lead to aggregation during concentration

  • Solution: Surface entropy reduction (SER) through mutation of surface-exposed residues with high conformational entropy (e.g., Lys, Glu) to alanine can enhance crystallizability

• Complex Formation Difficulties:

  • Transient Interactions: RRF's interactions with ribosomal components and EF-G are often transient, complicating structural studies of these complexes

  • Large Size: The complete RRF-ribosome complex is extremely large, presenting challenges for traditional crystallography

  • Solution: Cryo-electron microscopy has emerged as the method of choice for studying RRF-ribosome complexes, as it can capture transient states and accommodate large macromolecular assemblies

• Strain-Specific Considerations:

  • Sequence Variations: Subtle differences in RRF sequence between E. coli strains may affect structural features

  • Functional Implications: Correlating strain-specific structural variations with functional differences requires comparative approaches

  • Solution: Parallel structural studies of RRF from multiple strains, including O17:K52:H18, can identify conserved structural elements versus strain-specific features

Progress in addressing these challenges has been facilitated by innovative approaches:

By combining these advanced approaches, researchers can overcome the inherent challenges in structural studies of Recombinant E. coli O17:K52:H18 Ribosome-recycling factor, enabling more comprehensive understanding of its structure-function relationships .

How does the molecular mechanism of E. coli O17:K52:H18 Ribosome-recycling factor compare with other bacterial translation factors?

The molecular mechanism of E. coli O17:K52:H18 Ribosome-recycling factor exhibits distinct characteristics when compared to other bacterial translation factors, reflecting its specialized role in the final stage of protein synthesis:

• Structural Comparison with Other Translation Factors:

  Ribosome-recycling factor (RRF) possesses a unique structure among translation factors, consisting of two domains: a three-helix bundle (Domain I) connected to a three-stranded β-sheet (Domain II). This architecture differs significantly from other translation factors:

  Translation Factor	Structural Features	GTP Dependency	Ribosomal Binding Site
  RRF (frr product)	Two-domain structure with no GTPase activity	Requires EF-G and GTP for function	Overlaps with tRNA binding sites
  EF-Tu	Multi-domain GTPase	Direct GTP hydrolysis	A-site on small subunit
  EF-G	Five-domain GTPase	Direct GTP hydrolysis	Spans both ribosomal subunits
  RF1/RF2	Four-domain proteins with no GTPase activity	GTP-independent	A-site on small subunit

• Functional Mechanism Distinctions:

  RRF functions in a unique two-step process that differentiates it from other translation factors:

  • First Step: RRF binds to post-termination complexes, recognizing ribosomes with deacylated tRNA in the P-site

  • Second Step: EF-G-catalyzed GTP hydrolysis drives conformational changes that dissociate the ribosomal subunits

  This mechanism differs from release factors (RFs), which specifically recognize stop codons and catalyze peptide release, and from elongation factors, which facilitate aminoacyl-tRNA delivery and translocation during peptide elongation.

• Evolutionary Conservation Patterns:

  RRF is universally conserved across bacteria but absent in eukaryotes, which use a different mechanism for ribosome recycling. This makes RRF particularly valuable for antibiotic development. In contrast, many other translation factors have eukaryotic homologs, limiting their utility as antibiotic targets.

• Interaction Network Complexity:

  RRF exhibits a more specialized interaction network compared to other translation factors:

  • RRF primarily interacts with the 50S ribosomal subunit, particularly in regions overlapping with tRNA binding sites

  • Unlike elongation factors that interact extensively with both ribosomal subunits, RRF's interactions are more focused

  • While most translation factors interact with specific regions of mRNA, RRF functions independently of mRNA sequence

The essential nature of RRF for bacterial viability has been definitively established through experimental evidence. When the frr gene is inactivated or depleted, bacterial growth ceases entirely, demonstrating that this factor cannot be functionally replaced by any other component of the translation machinery .

What emerging technologies are advancing our understanding of Recombinant E. coli O17:K52:H18 Ribosome-recycling factor?

Emerging technologies are revolutionizing research on Recombinant E. coli O17:K52:H18 Ribosome-recycling factor, enabling unprecedented insights into its structure, function, and potential applications:

These emerging technologies are enabling transformative research outcomes:

The integration of these technologies is accelerating research on Recombinant E. coli O17:K52:H18 Ribosome-recycling factor, providing unprecedented insights into its fundamental biology and potential applications in antibiotic development .

What are the implications of studying Recombinant E. coli O17:K52:H18 Ribosome-recycling factor for broader translation research?

Research on Recombinant E. coli O17:K52:H18 Ribosome-recycling factor has far-reaching implications for our understanding of protein synthesis and the development of novel biotechnological applications:

• Fundamental Translation Mechanism Insights:

  • The study of RRF has revealed critical details about the final stage of protein synthesis that were previously poorly understood

  • RRF research has demonstrated that ribosome recycling is an active, energy-dependent process rather than a passive dissociation

  • Understanding the RRF mechanism provides insights into how bacteria optimize ribosome utilization, a key factor in growth efficiency

• Evolutionary Perspectives on Translation:

  • The presence of RRF in bacteria but not in eukaryotes highlights a fundamental divergence in translation termination mechanisms

  • Comparative studies between bacterial RRF and eukaryotic recycling factors (ABCE1) reveal how different evolutionary lineages have solved the same functional challenge through distinct molecular mechanisms

  • Analysis of RRF conservation across bacterial species provides insights into the evolution of the translation apparatus

• Biotechnological Applications:

  • Protein Expression Optimization: Methods developed for enhancing RRF expression, particularly N-terminal sequence optimization via directed evolution, have broad applicability for improving recombinant protein production

  • Cell-free Protein Synthesis: RRF is a critical component in cell-free protein synthesis systems, where optimized RRF variants can enhance translation efficiency and extend reaction lifetimes

  • Synthetic Biology Tools: Engineered RRF variants with altered activities could enable precise control over translation termination in synthetic biological systems

• Translational Medicine Relevance:

  • Antibiotic Development: The essential nature of RRF for bacterial survival makes it an attractive target for developing novel antibiotics to address antimicrobial resistance

  • Host-Pathogen Interactions: Understanding how bacterial pathogens regulate RRF activity during infection provides insights into adaptation mechanisms during host colonization

  • Bacterial Persistence: Research suggests connections between ribosome recycling efficiency and bacterial persistence, with implications for treating chronic infections

The methodologies developed for RRF research have broad applications in other areas of protein science:

By continuing to advance our understanding of Recombinant E. coli O17:K52:H18 Ribosome-recycling factor, researchers gain not only specific insights into this essential component of bacterial translation but also develop broadly applicable tools and concepts that benefit the wider field of translation research .

How might research on E. coli O17:K52:H18 Ribosome-recycling factor contribute to addressing antimicrobial resistance challenges?

Research on E. coli O17:K52:H18 Ribosome-recycling factor offers promising avenues for addressing the growing global crisis of antimicrobial resistance through multiple strategic approaches:

The practical implementation of RRF-based antimicrobial strategies includes several promising approaches:

The essential nature of RRF for bacterial growth has been definitively demonstrated through genetic experiments. E. coli strains with frame-shifted frr in the chromosome and wild-type frr on a temperature-sensitive plasmid could not grow at non-permissive temperatures, confirming that this factor is indispensable for cellular viability .